/
MTLS
$7.16+$0.09 (+1.27%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$410.6M
58M shares
52-week range
$4.78 – $7.23
97% from low
Exchange
NASDAQ
ADRC
Borrow rate
0.65%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-16.93
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $184.7M | $196.7M | $170.4M | $205.4M | $232.0M | $256.1M | $266.8M | $257.1M |
| Cost of revenue | $82.3M | $87.1M | $76.4M | $87.3M | $103.3M | $111.0M | $115.9M | $110.2M |
| Gross profit | $102.4M | $109.6M | $94.0M | $118.2M | $128.8M | $145.1M | $150.8M | $146.9M |
| Gross margin | 55.4% | 55.7% | 55.2% | 57.5% | 55.5% | 56.7% | 56.5% | 57.1% |
| R&D | $22.4M | $23.3M | $27.1M | $26.9M | $37.6M | $38.1M | $44.4M | $44.3M |
| Operating income | $5.2M | $6.9M | −$4.6M | $12.2M | −$2.9M | $5.6M | $9.4M | $4.9M |
| EBITDA | $19.9M | $19.7M | $13.8M | $36.7M | $23.4M | $30.1M | $31.2M | $25.8M |
| Net income | $3.0M | $1.6M | −$7.0M | $13.2M | −$2.1M | $6.7M | $13.4M | $7.4M |
| Net margin | 1.6% | 0.8% | -4.1% | 6.4% | -0.9% | 2.6% | 5.0% | 2.9% |
| EPS (diluted) | 0.06 | 0.03 | -0.14 | 0.24 | -0.04 | 0.11 | 0.23 | 0.13 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $278M | $0.18 | $0.17–$0.19 | 1 |
| 2027 | $296M | $0.25 | $0.19–$0.31 | 2 |
| 2028 | $325M | $0.39 | $0.38–$0.39 | 2 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$4.74
Price
$7.16
Implied downside
-34%
Peer comparison
Materialise NV
Materialise NV is a provider of 3D-printed medical devices and software and a pioneer in additive manufacturing software and services. The company operates through three principal segments: Materialise Software, Materialise Medical, and Materialise Manufacturing, with the Materialise Medical segment generating maximum revenue. The Materialise Medical segment develops and delivers medical software solutions, medical devices, and related products and services; the Materialise Software segment develops and delivers additive manufacturing software solutions and related services; and the Materialise Manufacturing segment delivers 3D-printed products and related services. The company generates maximum revenue from the United States of America.
www.materialise.com- Employees
- 2,556
- IPO / List date
- Jun 25, 2014
Held by traders on TradeandTell
No one on the platform currently holds MTLS.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 304,700 | $1.5M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded MTLS yet.
